James S. Scibetta, Director at Aquestive Therapeutics, Inc. (AQST), bought 22,971 shares at $3.77 ($87K) on 2019-08-19, disclosed to the SEC on 2019-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.77 | 10,761 | $41K | 46.6% |
| 2 | $3.80 | 11,310 | $43K | 49.4% |
| 3 | $3.81 | 900 | $3K | 3.9% |
| Total | $3.79 avg | 22,971 | $87K | 100% |
| Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |
| PCRX | SELL | 2016-11-17 | $730K | — | Filing → |